Marshall Elam in ‘People on the Move’
Dr. Marshall Elam, Professor, Department of Pharmacology, has been selected to be on the executive committee for the PROMINENT study, an international clinical trial that will test the effectiveness of a new cholesterol lowering medication called Pemafibrate and its effects on reducing the risk of heart attack and stroke.